Friday, April 12, 2019

Next Science's objective is to commercialise its proprietary technology for the treatment of biofilm protected bacteria, primarily in the area of human health and with potential applications in animal health and industrial segments.

The Company's proprietary Xbio technology is a non-toxic technology with proven efficacy in eradicating biofilm and biofilm protected bacteria. Xbio has been validated by extensive clinical testing, multiple FDA clearances and more than 70,000 patient treatments...

NXS - Next Science

from Aussie Stock Forums http://bit.ly/2GgmqcV

Related Posts:

  • LATEST STOCK MARKET NEWSIrdai approval is subject to RBI and Sebi approvals,” said a senior Irdai official, on condition of anonymity. from Stocks-Markets-The Economic Times https://ift.tt/2MEfw1b … Read More
  • LATEST STOCK MARKET NEWSBuy Lupin Ltd. at a price target of Rs 945.0 and a stop loss at Rs 880 from the entry point. from Stocks-Markets-The Economic Times https://ift.tt/2IKCukZ … Read More
  • LATEST STOCK MARKET NEWSMarket sentiment was negative amid mixed global cues. from Stocks-Markets-The Economic Times https://ift.tt/2MDNfI8 … Read More
  • LATEST STOCK MARKET NEWSMarket sentiment remained negative in the absence of any positive trigger amid sustained capital outflows. from Stocks-Markets-The Economic Times https://ift.tt/2tKIJAr … Read More
  • LATEST STOCK MARKET NEWSThree key valuation measures prove the stock’s long-term value, writes Gary Smith. from MarketWatch.com - Top Stories https://ift.tt/2tMqDhM … Read More

0 comments:

Post a Comment

Followers

Contact Form

Name

Email *

Message *

Popular Posts

FOLLOW BY EMAIL

Enter your email address:

Delivered by FeedBurner